The largest database of trusted experimental protocols

5 protocols using bosentan

1

Role of ET-1 in Hypertension Pathogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the role of ET‐1 plays in pathological hypertension, additional groups of eight‐ and thirteen‐week‐old SHRs (n = 4 in each group) were treated with an ET‐1 receptor antagonist. Briefly, the mesentery was incubated with 10 μM bosentan, an ET‐1 receptor antagonist (Med Chem Express, Monmouth Junction, NJ, USA) for 30 min. As mentioned above, lymphatic microcirculatory data were collected before and after 10 μM bosentan incubation were collected and analyzed. The lymphatic vasomotion profile, contractility and reflux were compared.
+ Open protocol
+ Expand
2

LDLr-Knockout Mice on Western Diet Treated with Bosentan

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eighteen male low-density lipoprotein receptor knockout mice (B6.129S7-Ldlrtm1Her/J on C57BL/6J background, Jackson Labs, Bar Harbor, MA) were individually housed and placed on a Western diet (Test Diet modified 58Y1, 5APC, Test Diet) at 12–13 weeks of age as a model of obesity and accelerated cardiovascular disease.48 (link) Concomitantly, all mice were administered ~54mg of reduced-fat peanut butter (6.7kcal/g of food, JIF, The J.M. Smucker Company, Orrville, OH) with versus without Bosentan, a dual ET-1 receptor antagonist (100mg/kg/day; Cat no. HY-A0013, MedchemExpress, Monmouth Junction, NJ) daily for eight weeks. Peanut butter, palatable to rodents, was used to keep the drug powder in suspension and ensure intake, which was monitored daily throughout the intervention. Following the eight-week intervention, aortas were harvested, and immediately used for vascular function assessment or flash frozen for Western blotting.
+ Open protocol
+ Expand
3

Cell Viability Assay under Stress Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with DMEM/high glucose (4.5 g/L) media containing 0.1% fetal bovine serum, DMEM/glucose-free media (09891-25; Nacalai Tesque) containing 0.1% fetal bovine serum, or DMEM/high glucose media containing 0.1% fetal bovine serum with tunicamycin (TM) (0.2 µg/mL, 35638-74; Nacalai Tesque). To assess cell viability, cells were cultured in the aforementioned medium with or without KUS121 (100 µM) and with bosentan (0; 100; 500; 2500 nM; MedChemExpress LLC, Monmouth Junction, NJ, USA), and/or endothelin-1 (0, 1, 10, 100 nM; Peptide, Osaka, Japan) and incubated at 37 °C for 40 h (under TM-stress conditions) or 48 h (under glucose-free conditions). In experiments involving 661W cells, KUS was added simultaneously with the stressor.
For cell viability assays, cells were washed using Dulbecco’s phosphate-buffered saline and incubated with Cell Count Reagent SF (07553-15; Nacalai Tesque) for 20 min. Using a Nivo Microplate reader (PerkinElmer, Waltham, MA, USA), the relative amount of live cells was subsequently determined by measuring the absorbance at 450 nm of the formazan produced by WST-8 reduction via intracellular dehydrogenase.
+ Open protocol
+ Expand
4

Investigating Endothelial Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wogonin, bosentan, and PDGF-BB were purchased from MedChemExpress (Israel Shekel). High-glucose Dulbecco’s Modified Eagle’s Medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco (Thermo Fisher Scientific Inc., Waltham, MA, USA). Phalloidin and Hochest 33342 were purchased from Abcam (Cambridge, UK). Primary antibodies specific for vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and HIF-1α were procured from ProteinTech (Chicago, IL, USA). Primary antibodies against NOX4, α-smooth muscle actin (α-SMA), and calponin 1 were purchased from Abcam (Cambridge, UK). The Cell Counting Kit-8 (CCK-8) assay was purchased from Dojindo Laboratories (Kumamoto, Japan). Other reagents and chemicals were all analytical grade.
+ Open protocol
+ Expand
5

Keratinocyte Growth and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Keratinocyte Basal Medium-2 (KBM-2) was purchased from Lonza (Walkersville, MD, USA). Collagenase A and Dispase II were obtained from Roche (Mannheim, Germany). P. gingivalis, P. gingivalis LPS, P. gingivalis LPS-ulp, HKLM and Pam3 were purchased from Invivogen (San Diego, CA, USA). BQ123 and BQ788 were obtained from American Peptides Company (Sunnyvale, CA, USA). Bosentan was a product of MedChem Express (Monmouth Junction, NJ, USA). U73122, U73433, PD98059, SP600125, SB203580, 2-aminoethoxydiphenyl borate (2-APB), 1,2-Bis(2-aminophenoxy)ethane-N, N, N’, N’-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM) and Escherichia coli LPS were products of Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!